ADVENT CAPITAL MANAGEMENT /DE/

Holdings History for BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1

Investment type: Debt / NOTE 1.500%10/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
30 Jun 2020		-0.35%	$0	0	-15,004,000	-100%		Q2 2020
31 Mar 2020	0.35%	-0.53%	$15,899,000	15,004,000	-22,777,000	-60%	105.97%	Q1 2020
31 Dec 2019	0.8%	-0%	$41,037,000	37,781,000	-162,000	-0.43%	108.62%	Q4 2019
30 Sep 2019	0.73%	+0.19%	$39,192,000	37,943,000	+9,687,000	+34%	103.29%	Q3 2019
30 Jun 2019	0.61%	+0.12%	$31,757,000	28,256,000	+5,412,000	+24%	112.39%	Q2 2019
31 Mar 2019	0.58%	-0.01%	$26,075,000	22,844,000	-309,000	-1.3%	114.14%	Q1 2019
31 Dec 2018	0.63%	-0.04%	$25,858,000	23,153,000	-1,482,000	-6%	111.68%	Q4 2018
30 Sep 2018	0.61%	-0.01%	$29,496,000	24,635,000	-386,000	-1.5%	119.73%	Q3 2018
30 Jun 2018	0.63%	-0.02%	$29,619,000	25,021,000	-824,000	-3.2%	118.38%	Q2 2018
31 Mar 2018	0.57%	+0.04%	$28,571,000	25,845,000	+1,800,000	+7.5%	110.55%	Q1 2018
31 Dec 2017	0.55%	-0.04%	$28,517,000	24,045,000	-1,760,000	-6.8%	118.6%	Q4 2017
30 Sep 2017	0.59%	-0.02%	$31,041,000	25,805,000	-841,000	-3.2%	120.29%	Q3 2017
30 Jun 2017	0.61%	-0.01%	$31,736,000	26,646,000	-578,000	-2.1%	119.1%	Q2 2017
31 Mar 2017	0.61%	-0%	$32,366,000	27,224,000	-153,000	-0.56%	118.89%	Q1 2017
31 Dec 2016	0.6%	+0.02%	$32,334,000	27,377,000	+778,000	+2.9%	118.11%	Q4 2016
30 Sep 2016	0.48%	-0.03%	$33,221,000	26,599,000	-1,436,000	-5.1%	124.9%	Q3 2016
30 Jun 2016	0.5%	+0.02%	$32,497,000	28,035,000	+977,000	+3.6%	115.92%	Q2 2016
31 Mar 2016	0.49%	+0.05%	$32,137,000	27,058,000	+3,000,000	+12%	118.77%	Q1 2016
31 Dec 2015	0.5%	+0.03%	$32,458,000	24,058,000	+1,504,000	+6.7%	134.92%	Q4 2015
30 Sep 2015	0.47%	-0.07%	$30,444,000	22,554,000	-3,204,000	-12%	134.98%	Q3 2015
30 Jun 2015	0.59%	0%	$41,264,000	25,758,000	0		160.2%	Q2 2015
31 Mar 2015	0.64%	-0.02%	$44,549,000	29,503,000	-756,000	-2.5%	151.0%	Q1 2015
31 Dec 2014	0.54%	-0.1%	$36,807,000	30,259,000	-5,504,000	-15%	121.64%	Q4 2014
30 Sep 2014	0.61%	0%	$39,268,000	35,763,000	0		109.8%	Q3 2014
30 Jun 2014	0.6%	-0.04%	$38,870,000	35,763,000	-2,666,000	-6.9%	108.69%	Q2 2014
31 Mar 2014	0.68%	-0.15%	$42,798,000	38,429,000	-8,371,000	-18%	111.37%	Q1 2014
31 Dec 2013	0.63%	0%	$50,350,000	46,800,000	0		107.59%	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.